^
No biomarker
Thyroid Gland Papillary Carcinoma
sorafenib
Sensitive
:
A1
No biomarker
Thyroid Gland Papillary Carcinoma
lenvatinib
Sensitive
:
A1
NTRK2 fusion
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
A2
No biomarker
Thyroid Gland Papillary Carcinoma
denosumab
Sensitive
:
A2
RET fusion
Thyroid Gland Papillary Carcinoma
selpercatinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Papillary Carcinoma
entrectinib
Sensitive
:
A2
NTRK2 fusion
Thyroid Gland Papillary Carcinoma
entrectinib
Sensitive
:
A2
NTRK1 fusion
Thyroid Gland Papillary Carcinoma
entrectinib
Sensitive
:
A2
NTRK3 fusion
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
A2
NTRK1 fusion
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
A2
TMB-H
Thyroid Gland Papillary Carcinoma
pembrolizumab
Sensitive
:
A2
RET fusion
Thyroid Gland Papillary Carcinoma
pralsetinib
Sensitive
:
A2
BRAF V600E
Thyroid Gland Papillary Carcinoma
trametinib + dabrafenib
Sensitive
:
C1
BRAF V600E
Thyroid Gland Papillary Carcinoma
vemurafenib
Sensitive
:
C1
BRAF mutation
Thyroid Gland Papillary Carcinoma
trametinib + dabrafenib
Sensitive
:
C2
BRAF mutation
Thyroid Gland Papillary Carcinoma
PLX8394 + cobicistat
Sensitive
:
C3
BRAF V600
Thyroid Gland Papillary Carcinoma
BGB-283
Sensitive
:
C3
BRAF mutation
Thyroid Gland Papillary Carcinoma
dabrafenib
Sensitive
:
C3
BRAF V600E
Thyroid Gland Papillary Carcinoma
siltuximab
Sensitive
:
C4
PDGFRB overexpression
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
C4
EGFR overexpression
Thyroid Gland Papillary Carcinoma
larotrectinib
Sensitive
:
C4
BRAF V600
Thyroid Gland Papillary Carcinoma
dabrafenib + SNR1611
Sensitive
:
C4
NCOA4-RET fusion
Thyroid Gland Papillary Carcinoma
lenvatinib
Sensitive
:
C4
TPM3-NTRK1 fusion
Thyroid Gland Papillary Carcinoma
AB106
Sensitive
:
C4
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our